Allan Gopez
YOU?
Author Swipe
View article: LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples
LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples Open
Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2–3 separate reactions or rely on detection of a single viral target, which adds significant …
View article: LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples
LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples Open
Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2–3 separate reactions or rely on detection of a single viral target, which adds significant …
View article: Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid
Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid Open
This case-control study showed that CSF mNGS, which has low specimen volume requirements, does not require the preservation of cell integrity, and was orginally developed to diagnose neurologic infections, can also detect genetic evidence …
View article: Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids Open
View article: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Open
Importance Malignant neoplasms of the central nervous system (CNS) are frequently not detected by cerebrospinal fluid (CSF) flow cytometry or cytology, and clinical phenotypes can overlap with inflammatory meningoencephalitis. Objective To…
View article: Detection of Cryptogenic Malignancies from Metagenomic Whole Genome Sequencing of Body Fluids
Detection of Cryptogenic Malignancies from Metagenomic Whole Genome Sequencing of Body Fluids Open
Detection of Cryptogenic Malignancies from Metagenomic Whole Genome Sequencing of Body Fluids Wei Gu1,2,3,4*, Eric Talevich5, Elaine Hsu1, Zhongxia Qi1, Anatoly Urisman6
View article: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Open
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Wei Gu, MD, PhD1,2*, Andreas M. Rauschecker, MD, PhD3, Elaine Hsu, BS1, Kelsey C. Zorn, BS4, Yasemin Sucu, BS1, …
View article: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Open
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Wei Gu1,2*, Andreas M. Rauschecker3, Elaine Hsu1, Kelsey C. Zorn4, Yasemin Sucu1, Scot Federman1, All…
View article: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Open
Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Wei Gu, MD, PhD1,2*, Andreas M. Rauschecker, MD, PhD3, Elaine Hsu, BS1, Kelsey C. Zorn, BS4, Yasemin Sucu, BS1, …
View article: A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood Open
SARS-CoV-2 infection elicits a distinct host response in nasal swabs and blood that can be used to diagnose COVID-19.
View article: Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification
Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification Open
View article: Additional file 2 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Additional file 2 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids Open
Additional file 2: Table S1. Body fluid samples from patients positive for malignancy by cytology and/or flow cytometry.
View article: Additional file 3 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Additional file 3 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids Open
Additional file 3: Table S2. Select microbiological cases that have overlapping features with cancer presentations.
View article: Additional file 4 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Additional file 4 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids Open
Additional file 4: Table S3. Microbiological cases - all other cases.
View article: Additional file 5 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
Additional file 5 of Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids Open
Additional file 5: Table S4. Verification cohort.
View article: Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids Open
View article: Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification
Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification Open
The COVID-19 pandemic caused by the SARS-CoV-2 virus motivates diverse diagnostic approaches due to the novel causative pathogen, incompletely understood clinical sequelae, and limited availability of testing resources. Given the variabili…
View article: Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays
Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays Open
Analytical sensitivity for SARS-CoV-2 detection is a key performance metric for the evaluation of viral detection assays. We determined analytical limits of detection for seven SARS-CoV-2 assays using serial dilutions of pooled patient mat…
View article: Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California Open
Epidemic in Northern California Genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks is valuable for tracing the sources and perhaps for drawing lessons about preventing future outbreaks. Genomic anal…
View article: CRISPR–Cas12-based detection of SARS-CoV-2
CRISPR–Cas12-based detection of SARS-CoV-2 Open
View article: A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage Open
The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has spread globally, resulting in >300,000 reported cases worldwide as of March 21st, 2020. Here we investigate the genetic diversity and genomic epidemiology of SARS-CoV-2 i…
View article: Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay
Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay Open
An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the devel…